Go Pro

Bank of America Corp DE Has $82.38 Million Stock Position in Amdocs Limited $DOX

Amdocs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Bank of America increased its Amdocs stake by 29.1% in the first quarter, holding 1.26 million shares worth approximately $82.4 million. Institutional investors and hedge funds collectively own 92.02% of Amdocs.
  • Analyst sentiment is mixed, with three Buy, three Hold, and one Sell rating. Amdocs has an overall “Hold” rating and an average price target of $86.67, despite recent target cuts and downgrades.
  • Amdocs reported quarterly EPS of $1.84, matching estimates, while revenue rose 2.7% year over year to $1.17 billion. The company declared a quarterly dividend of $0.569, equivalent to a 3.9% annualized yield.
  • Interested in Amdocs? Here are five stocks we like better.

Bank of America Corp DE grew its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 29.1% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,262,263 shares of the technology company's stock after acquiring an additional 284,435 shares during the quarter. Bank of America Corp DE owned 1.17% of Amdocs worth $82,375,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of DOX. WealthCollab LLC raised its stake in Amdocs by 94.5% in the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company's stock worth $29,000 after purchasing an additional 173 shares in the last quarter. BOK Financial Private Wealth Inc. acquired a new position in shares of Amdocs during the 4th quarter worth approximately $37,000. Los Angeles Capital Management LLC acquired a new position in shares of Amdocs during the 4th quarter worth approximately $39,000. Advisory Services Network LLC bought a new position in shares of Amdocs during the third quarter worth approximately $42,000. Finally, CIBC Private Wealth Group LLC increased its holdings in shares of Amdocs by 190.2% during the third quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company's stock worth $49,000 after purchasing an additional 390 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on DOX shares. Stifel Nicolaus cut their price target on Amdocs from $88.00 to $71.00 and set a "buy" rating for the company in a research note on Thursday, May 14th. KeyCorp assumed coverage on Amdocs in a research note on Monday, June 29th. They set a "sector weight" rating on the stock. Wall Street Zen cut Amdocs from a "buy" rating to a "hold" rating in a report on Sunday, July 5th. Cfra downgraded Amdocs to a "sell" rating in a research report on Thursday, May 14th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Amdocs in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Amdocs presently has an average rating of "Hold" and an average target price of $86.67.

Read Our Latest Report on DOX

Amdocs Stock Performance

Shares of Amdocs stock opened at $58.55 on Monday. The company has a current ratio of 0.94, a quick ratio of 0.98 and a debt-to-equity ratio of 0.23. The company has a market cap of $6.32 billion, a PE ratio of 13.94, a price-to-earnings-growth ratio of 1.02 and a beta of 0.40. The company has a 50 day moving average of $54.41 and a 200-day moving average of $63.15. Amdocs Limited has a 1-year low of $49.74 and a 1-year high of $90.29.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The technology company reported $1.84 EPS for the quarter, meeting the consensus estimate of $1.84. Amdocs had a net margin of 9.75% and a return on equity of 20.28%. The business had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.18 billion. During the same period in the previous year, the business earned $1.72 earnings per share. The company's revenue was up 2.7% on a year-over-year basis. Amdocs has set its Q4 2026 guidance at 1.940-2.000 EPS and its FY 2026 guidance at 7.374-7.444 EPS. As a group, equities research analysts forecast that Amdocs Limited will post 6.56 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date is Wednesday, September 30th. Amdocs's dividend payout ratio (DPR) is presently 54.05%.

About Amdocs

(Free Report)

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

Featured Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines